Trials / Sponsors / Zhigang Li
Zhigang Li
Academic / Other · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy ESCC | Phase 2 | 2026-03-15 |
| Not Yet Recruiting | Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC Esophageal Squamous Cell Carcinoma | Phase 2 | 2025-07-01 |
| Recruiting | Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. Resectable Esophageal Squamous Cell Carcinoma | Phase 3 | 2021-09-01 |